MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Biodel Company Profile (NASDAQ:BIOD)

Consensus Ratings for Biodel (NASDAQ:BIOD) (?)
Ratings Breakdown: 3 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.00 (542.67% upside)

Analysts' Ratings History for Biodel (NASDAQ:BIOD)
Show:
DateFirmActionRatingPrice TargetActions
12/18/2015Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015WedbushReiterated RatingNeutral$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Roth CapitalInitiated CoverageBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Biodel (NASDAQ:BIOD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
5/9/2016Q2($0.04)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2016Q1($0.08)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/17/2015Q315($0.11)($0.05)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q3($0.10)($0.12)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q215($0.23)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q115($0.17)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/17/2014Q414($0.25)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014($0.26)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114($0.24)($0.29)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q4($0.19)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/18/2013Q4($0.32)($0.04)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2013Q3 2013($0.37)($0.66)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q2 2013($0.43)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Biodel (NASDAQ:BIOD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161($0.05)($0.05)($0.05)
Q1 20171($0.05)($0.05)($0.05)
Q2 20171($0.05)($0.05)($0.05)
Q3 20171($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)
Dividend History for Biodel (NASDAQ:BIOD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Biodel (NASDAQ:BIOD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/20/2013Brian Jg PereiraDirectorSell4,734$2.26$10,698.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Biodel (NASDAQ:BIOD)
DateHeadline
06/28/16 03:01 PMPen Needles Market Forecast to Grow at 11.2% CAGR to 2021 led by Standard Needles Segment
06/27/16 02:29 PMNew Broker Ratings For Biodel Inc. (BIOD) - FTSE News
06/23/16 10:17 PMBiodel Inc. (NASDAQ:BIOD) Earnings Glance and Target Price Review - Engelwood Daily
06/21/16 07:36 AMRecently Issued Stock Ratings For Biodel Inc. (BIOD) - Fiscal Standard
06/16/16 08:13 PMType 1 Diabetes Market : Size, Share, Development, Growth and Demand Forecast to 2015 – 2021
06/16/16 07:13 AMNotable Stocks within Investor Radar: Biodel Inc. (NASDAQ:BIOD) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/15/16 02:53 PMHave a look at Price Moves: Depomed, Inc. (NASDAQ:DEPO) , Biodel Inc. (NASDAQ:BIOD) - Street Updates
06/03/16 08:55 PMStock Review and Earnings Check on Biodel Inc. (NASDAQ:BIOD) - HNN
06/03/16 02:55 PMEarnings Trends of the Stock: Biodel Inc. (NASDAQ:BIOD), OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Beacon Chronicle
06/03/16 11:25 AMBiotech Stocks within Traders Radar: Immunomedics, Inc. (NASDAQ:IMMU) , Biodel Inc. (NASDAQ:BIOD) - Is stories
06/01/16 11:20 AMTarget Price and Stock Performance Rundown for Biodel Inc. (NASDAQ:BIOD) - HNN - Target Price and Stock Performance Rundown for Biodel Inc. (NASDAQ:BIOD)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, Biodel Inc. (NASDAQ:BIOD) shares ...and more »
05/31/16 02:52 PMLatest Analysts Tips Update: Johnson & Johnson (NYSE:JNJ) , Biodel Inc. (NASDAQ:BIOD) - Street Updates - Latest Analysts Tips Update: Johnson & Johnson (NYSE:JNJ) , Biodel Inc. (NASDAQ:BIOD)Street UpdatesJohnson & Johnson (NYSE:JNJ) accumulated +0.14%, closing at $113.06 after floating between $112.69 and $113.34. The company has market capitalization of $310.99B. It has twelve month low of $81.79 and twelve month high of $115.00. The recent ...and more »
05/29/16 02:03 PMHow Analysts Feel About Biodel Inc (NASDAQ:BIOD)? - HNN - How Analysts Feel About Biodel Inc (NASDAQ:BIOD)?HNNOut of 1 analysts covering Biodel (NASDAQ:BIOD), 0 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 0% are positive. Biodel has been the topic of 2 analyst reports since December 18, 2015 according to StockzIntelligence Inc. Below is a list of ...Biodel Inc. (NASDAQ:BIOD) One-Year Price Target At $3.500Equities FocusBiodel Inc. (NASDAQ:BIOD) Quarterly EPS From Continuing Operations Stands At $-0.0915Investor Newswireall 3 news articles »
05/28/16 01:38 PMEarnings Review and Stock Rundown for Biodel Inc. (NASDAQ:BIOD) - Wall Street Hints and News - Earnings Review and Stock Rundown for Biodel Inc. (NASDAQ:BIOD)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Biodel Inc. (NASDAQ:BIOD) to post ...and more »
05/28/16 01:38 PMHC Stocks Updates: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Biodel Inc (NASDAQ:BIOD) - share market updates (press release) - share market updates (press release)HC Stocks Updates: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Biodel Inc (NASDAQ:BIOD)share market updates (press release)Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) ended Thursday session in red amid volatile trading. The shares closed down -0.12 points or -1.47% at $8.03 with 2.00 million shares getting traded. Post opening the session at $8.14, the shares hit ...
05/28/16 01:38 PMAnalyst Rating Trends to Observe: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Biodel Inc. (NASDAQ:BIOD) - Street Updates - The Point ReviewAnalyst Rating Trends to Observe: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Biodel Inc. (NASDAQ:BIOD)Street UpdatesBiodel Inc. (NASDAQ:BIOD) showed bearish move with loss of -20.217% after exchanging volume of 3.02 million shares in last trading session ended on 5/26/2016. The company recent traded volume was higher than its average volume of 1.21 million shares ...Drug-Makers on Vanguard Level- Biodel (NASDAQ:BIOD), Pernix Therapeutics (NASDAQ:PTX)Seneca Globeall 33 news articles »
05/28/16 01:38 PMBiotech Stock Picking: Biodel Inc (NASDAQ:BIOD) - The Point Review - The Point ReviewBiotech Stock Picking: Biodel Inc (NASDAQ:BIOD)The Point ReviewShare of Biodel Inc (NASDAQ:BIOD) traded on -9.47 percent below secure line at 2:33PM EDT in order to take the company's stock at the price of $0.325. At the time of writing the stock exchanged hands 1.84 million shares versus average trading capacity ...Biodel Inc. (NASDAQ:BIOD) Closes At $0.3670Markets DailyBroker Changes For Biodel Inc. (BIOD)Risers & FallersHealthcare Worth Watching Stocks : Biodel Inc (NASDAQ:BIOD), Bristol-Myers Squibb Co (NYSE:BMY)NYSE Journal (press release)Street Updates -CWRU Observerall 14 news articles »
05/26/16 01:42 PMStocks Moving Upward: Citigroup Inc (NYSE:C), Biodel Inc (NASDAQ:BIOD) - NYSE Journal (press release) - NYSE Journal (press release)Stocks Moving Upward: Citigroup Inc (NYSE:C), Biodel Inc (NASDAQ:BIOD)NYSE Journal (press release)Citigroup Inc (NYSE:C), belongs to Financial sector and Money Center Banks industry. C stock opened its current trade at $46.19 and now floating in a range of $46.19 to $47.60, trading at $46.89. C stock gain 2.24% in total of its share price. C stock ...and more »
05/26/16 01:42 PMHealthcare stocks to Observe: Biodel Inc. (NASDAQ:BIOD) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Is stories - Is storiesHealthcare stocks to Observe: Biodel Inc. (NASDAQ:BIOD) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO)Is storiesBiodel Inc. (NASDAQ:BIOD) increased +21.05% to $0.46 while traded 9.49 million shares on 5/25/2016. The stock price negotiated for value between $0.42 to $0.53 in recent trading session. During the past 52 weeks, the stock's price witnessed a minimum ...and more »
05/26/16 07:08 AMBIODEL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -
05/25/16 12:58 PMBiodel Inc. (NASDAQ:BIOD) Closes At $0.3900 - Investor Newswire - Biodel Inc. (NASDAQ:BIOD) Closes At $0.3900Investor NewswireYesterday, the stock of Biodel Inc. (NASDAQ:BIOD) closed at $0.3900 after opening at $0.4000 and registering high of $0.4059 and low of $0.3812. The last price is $-0.7803 off 1-year high of $1.1800 and $0.1797 away from low of $0.2200 during same ...and more »
05/25/16 12:58 PMStocks Movements to Focus: Cerus Corporation (NASDAQ:CERS) , Biodel Inc. (NASDAQ:BIOD) - Street Updates - Stocks Movements to Focus: Cerus Corporation (NASDAQ:CERS) , Biodel Inc. (NASDAQ:BIOD)Street UpdatesOn 5/20/2016, Cerus Corporation (NASDAQ:CERS) ended trading session higher at $5.20 with +2.56%. The company traded a volume of 1.52 million shares as comparison to average volume of 1.22 million shares. During the 52 –week period, the stock's ...and more »
05/25/16 11:54 AMBIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
05/25/16 08:38 AMBiodel/Albireo Limited to Combine; Focus on Liver Diseases -
05/25/16 01:52 AM2:52 am Biodel and Albireo agree to combine through share exchange agreement -
05/24/16 07:04 PMBiodel Inc. and Albireo Limited Agree to Combine - [Marketwired] - Biodel Inc. Transaction to result in NASDAQ-listed company focused in orphan pediatric liver diseases Albireo brings wholly owned, Phase 2 lead asset A4250 to treat Progressive Familial Intrahepatic......
05/24/16 01:22 PMAWS Morning Technical Breakdown Highlights: Novo Nordisk, Biodel, Sucampo Pharma, and SciClone Pharma - Additionally, Novo Nordisk’s stock has a Relative Strength Index (RSI) of 44.11. Shares of specialty biopharmaceutical company, Biodel Inc., ended the session at $0.39, gaining 1.59%. The stock recorded a trading volume of 1.05 million shares.
05/20/16 01:10 PMLatest Analyst Ratings For Biodel Inc. (BIOD) - Share Trading News - Latest Analyst Ratings For Biodel Inc. (BIOD)Share Trading News12/18/2015 – Biodel Inc. was downgraded to “market perform” by analysts at William Blair. 10/14/2015 – Biodel Inc. had its “neutral” rating reiterated by analysts at Wedbush. They now have a USD 2 price target on the stock. 05/18/2015 – Roth Capital ...
05/18/16 01:27 PMRevenue Update on Biodel Inc(NASDAQ:BIOD) - Trade Calls - Revenue Update on Biodel Inc(NASDAQ:BIOD)Trade CallsBiodel Inc(NASDAQ:BIOD) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on May 9, 2016. Earnings per share were $-0.09. Analysts had estimated an EPS of $-0.04. Biodel Inc (BIOD) shares turned ...
05/17/16 01:41 PMBiodel Inc. (NASDAQ:BIOD) Hovering Around $0.3975 - Investor Newswire - Biodel Inc. (NASDAQ:BIOD) Hovering Around $0.3975Investor NewswireOn performing technical analysis of Biodel Inc. (NASDAQ:BIOD) stock, it is noted that the stock is $0.0105 points away +2.7360% from its fifty-day MA of $0.3843. It is $0.0697 or +21.4227% away $0.3251, the 200-day MA (Moving Average) of stock. Also ...
05/17/16 01:41 PMUpdated Trading Report: VWR Corporation (NASDAQ:VWR) , Biodel Inc. (NASDAQ:BIOD) - Street Updates - Updated Trading Report: VWR Corporation (NASDAQ:VWR) , Biodel Inc. (NASDAQ:BIOD)Street UpdatesOn 5/13/2016, shares of VWR Corporation (NASDAQ:VWR) rose +0.14% in trading session and finally closed at $28.70. The company most recent volume stood at 627.6 thousand shares as compared to its average volume of 786.1 thousand shares. Over the ...and more »
05/13/16 07:18 AMHC Stocks Highlights: Pfizer Inc. (PFE), Biodel Inc (BIOD), AbbVie Inc (ABBV) - share market updates (press release) - HC Stocks Highlights: Pfizer Inc. (PFE), Biodel Inc (BIOD), AbbVie Inc (ABBV)share market updates (press release)Shares of Pfizer Inc. (NYSE:PFE) ended Thursday session in green amid volatile trading. The shares closed up +0.05 points or 0.15% at $33.21 with 25.38 million shares getting traded. Post opening the session at $33.22, the shares hit an intraday low of ...and more »
05/12/16 07:30 AMPerformance Recap and Target Perspective on Biodel Inc. (NASDAQ:BIOD) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Biodel Inc. (NASDAQ:BIOD)B.O.D.Y ConfidentialIn the latest trading session, shares of Biodel Inc. (NASDAQ:BIOD) moved -0.258%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, company shares ...and more »
05/11/16 06:43 AMPrice Target Summary: Biodel Inc (NASDAQ:BIOD) - News Oracle - Price Target Summary: Biodel Inc (NASDAQ:BIOD)News OracleLast Trade: The Company rose 8.92% and finished at $0.414. The daily volume was measured at 1.97 million shares. The 52-week high of the share price is $1.23 and the 52-week low is $0.22. The company has a market cap of $26.55 million. Its latest ...and more »
05/11/16 06:43 AMHC Stocks Review: Biodel Inc (BIOD), Synergy Pharmaceuticals Inc (SGYP), Endo International plc (ENDP) - share market updates (press release) - HC Stocks Review: Biodel Inc (BIOD), Synergy Pharmaceuticals Inc (SGYP), Endo International plc (ENDP)share market updates (press release)Shares of Biodel Inc (NASDAQ:BIOD) ended Tuesday session in red amid volatile trading. The shares closed down -0.027 points or -6.50% at $0.387 with 1.71 million shares getting traded. Post opening the session at $0.39, the shares hit an intraday low ...and more »
05/10/16 03:03 PMBIODEL INC Files SEC form 10-Q, Quarterly Report -
05/10/16 07:02 AMRecent HC Trading Updates: Biodel Inc (BIOD), Teva Pharmaceutical Industries Ltd (TEVA), Exelixis Inc. (EXEL) - share market updates (press release) - share market updates (press release)Recent HC Trading Updates: Biodel Inc (BIOD), Teva Pharmaceutical Industries Ltd (TEVA), Exelixis Inc. (EXEL)share market updates (press release)Shares of Biodel Inc (NASDAQ:BIOD) ended Monday session in green amid volatile trading. The shares closed up +0.034 points or 8.92% at $0.414 with 1.97 million shares getting traded. Post opening the session at $0.41, the shares hit an intraday low of ...and more »
05/10/16 07:02 AMCompany Update (NASDAQ:BIOD): Biodel Inc Reports Second Quarter Fiscal Year 2016 Financial Results - Smarter Analyst - Smarter AnalystCompany Update (NASDAQ:BIOD): Biodel Inc Reports Second Quarter Fiscal Year 2016 Financial ResultsSmarter Analyst“As we continue to diligently evaluate strategic alternatives to create shareholder value, we have significantly reduced our operating cash burn and anticipate further reductions in expenses,” said Gary Gemignani, Biodel's interim CEO. “On an operating ...
05/10/16 07:02 AMBRIEF-Biodel Inc reports Q2 loss per share $0.09 - Reuters - BRIEF-Biodel Inc reports Q2 loss per share $0.09ReutersBRIEF-Biodel Inc reports Q2 loss per share $0.09. May 9 Biodel Inc. * Biodel reports second quarter fiscal year 2016 financial results. * Q2 loss per share $0.09 Source text for Eikon: Further company coverage: ...
05/09/16 04:37 PMBIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
05/09/16 04:00 PMBiodel Reports Second Quarter Fiscal Year 2016 Financial Results - [Marketwired] - Biodel Inc. today reported financial results for the second fiscal quarter ended March 31, 2016."As we continue to diligently evaluate strategic alternatives to create shareholder value, we have significantly ...
05/06/16 07:16 AMHC Stocks Focal Point: Arrowhead Pharmaceuticals Inc (ARWR), Athersys Inc. (ATHX), Biodel Inc (BIOD) - share market updates (press release) - share market updates (press release)HC Stocks Focal Point: Arrowhead Pharmaceuticals Inc (ARWR), Athersys Inc. (ATHX), Biodel Inc (BIOD)share market updates (press release)Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) ended Thursday session in red amid volatile trading. The shares closed down -0.07 points or -1.22% at $5.67 with 416,715.00 shares getting traded. Post opening the session at $5.74, the shares ...
04/01/16 04:02 PMBIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
03/24/16 08:15 AMBIODEL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf -
03/02/16 04:49 PMBIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers -
02/19/16 12:04 PMBIODEL INC Financials -
02/16/16 06:05 AMBiodel Reports First Quarter Fiscal Year 2016 Financial Results - [Marketwired] - Biodel Inc. today reported financial results for the first fiscal quarter ended December 31, 2015. Corporate updates since last fiscal quarter: In October 2015, the company committed to a restructuring ...
01/29/16 07:00 AMBiodel Announces Restructuring Update - [Marketwired] - Biodel Inc. today announced updates regarding the company's ongoing strategy to preserve its assets and maximize shareholder value.In January 2016, the company completed a reduction in force affecting ...
01/27/16 03:33 PMBIODEL INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities -
12/28/15 07:25 AMAuris Medical Holding (EARS) Looks Good: Stock Up 23.8% -
About Biodel

Biodel logoBiodel Inc. is a specialty biopharmaceutical company. The Company focuses on the development and commercialization of treatments for diabetes. The Company is engaged in developing product candidates by applying its formulation technologies to existing drugs. The Company is engaged in developing room temperature stable glucagon presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia. It also develops insulin formulations for Type 1 and Type 2 diabetes patients. Its product pipeline includes RHI-based Ultra-Rapid-Acting Insulin, Analog-based Ultra-Rapid-Acting Insulin, Concentrated Ultra-Rapid-Acting Insulin and Glucagon. The Company's BIOD-531 is a Concentrated Ultra-Rapid-Acting Insulin and its insulin analog-based ultra-rapid-acting insulin product candidates include BIOD-123, BIOD-531, BIOD-238 and BIOD-250. It also conducts pre-clinical testing to develop liquid formulations of glucagon for hypoglycemic rescue and other indications.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOD
  • CUSIP:
Key Metrics:
  • Previous Close: $0.31
  • 50 Day Moving Average: $0.3471
  • 200 Day Moving Average: $0.3287
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $19.96M
  • Current Quarter EPS Consensus Estimate: $-0.1700 EPS
Additional Links:
Biodel (NASDAQ:BIOD) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha